A due acknowledgment to management re summary update of year occurrences and projections to come.
As the 3 keys of an relationship are; similarity, proximity and familiarity, that later two connect us shareholders to behind the scenes events via communication and updates. The initiation of the shareholders update and this summary are, I’m quite sure, appreciated by many.
But please, stay within no more than 5 posts per week (the golden rule here) just as us shareholders try.
Jokes apart, the lift of the breast cancer trial should see PTX’s darkest moment behind..., waiting on the final analysis report of the 1b trail and , most importantly, the dosage setting, design and recruitment of participants for the breast cancer 2a trial.
Hopefully be in person to greet some of this professional team and of course fellow shareholders at the next AGM.
PTX Price at posting:
6.7¢ Sentiment: Buy Disclosure: Held
